RFK Jr. fired everyone on a key vaccine panel. Here's who he replaced them with.
Health Secretary Robert F. Kennedy Jr. announced this week that he had removed every member of an independent panel key to vaccine policy and access in America. After removing the 17 members of the panel, Kennedy announced eight new names, many of whom have been skeptical of vaccines.
The Advisory Committee for Immunization Practices (ACIP), which works under the Centers for Disease Control and Prevention, was recently made up of people with extensive experience in public health, infectious diseases and immunizations. For more than half a century, the panel of experts has used evidence-based data to help evaluate the safety of vaccines that are administered to people — and their guidance is used by insurance companies to determine coverage.
Kennedy, a vaccine skeptic, claimed the move was aimed at addressing conflicts of interest, though the panel had operated under a comprehensive conflict of interest policy. The unprecedented shakeup could change what vaccines are readily available in the future, including whether they are covered by insurance. Without insurance, some vaccines — including those for COVID-19, HPV and measles, mumps and rubella — could cost people hundreds of dollars out-of-pocket.
It's not clear if Kennedy will appoint more members. Here's what to know about his picks:
Who is he? A nutritional scientist who has worked as a psychiatrist and professor. His experience on nutritional neurosciences includes a stint as acting chief within the National Institute on Alcohol Abuse and Alcoholism. In 2018, Hibbeln co-authored research that tested whether a person's fish consumption during the first half of pregnancy is associated with autism.
Vaccine experience: Hibbeln has no professional background in vaccines.
Who is he? A biostatistician and epidemiologist who is a former professor of medicine at Harvard University.
Vaccine experience: Kulldorf has served on a vaccine safety subgroup within ACIP and was a member of an FDA drug safety and risk management advisory committee. He is known for researching the development of vaccine safety surveillance and the monitoring of infectious disease outbreaks.
Kulldorf has been highly skeptical of COVID-19 vaccines and related government policies and mandates. In 2024, he said he lost jobs at Harvard and Mass General Brigham because he criticized policies that mandated COVID-19 vaccination.
In late 2020, he co-authored the Great Barrington Declaration, which proposed reaching herd immunity for COVID-19 through 'natural' infection instead of public health restrictions. He co-wrote the declaration with Dr. Jay Bhattacharya, who was critical of COVID-19 restrictions and is now director of the National Institutes of Health. Kulldorf has aligned publicly with Kennedy on changing the process for vaccine trials.
Who is he? A professor of operations management at the Massachusetts Institute of Technology. According to his university biography, his research includes examining data models and tools used in health care management. Levi has described his work as using data and analytics to assess and manage risk in health systems.
Vaccine experience: Levi has no professional background in vaccines.
He has challenged the safety of COVID-19 vaccines and its impact on young people. In May, Levi expressed ongoing skepticism of the safety of administering COVID-19 vaccines to pregnant people, despite evidence of its benefits.
Who is he? A medical doctor and infectious disease researcher who has gained national attention within right-wing media for his criticism of COVID-19 vaccines.
Vaccine experience: After the news of his addition to the panel, Malone shared a biography that asserts years of experience in developing and testing vaccines.
But Malone has spread misinformation about COVID-19 vaccines. He has claimed credit for inventing mRNA vaccines that have been critical to the fast development of COVID-19 vaccines — an assertion that has been challenged — while also questioning their safety. Malone said in April that the second child who died of measles this year had actually died from other complications, a claim that went against public health officials' statements.
Who is he? A professor of pediatrics at Dartmouth University, Meissner served on the committee between 2008 and 2012. Since 2018, he has served on another committee that advises the Food and Drug Administration on vaccines.
Vaccine experience: Meissner has in the past defended vaccines, writing in a 2022 article for the New England Journal of Medicine that 'widespread understanding and acceptance of vaccines will be an integral aspect' of limiting the harm of future pandemics.
He also helped craft vaccine schedules for the American Academy of Pediatrics, and in 2017 was named the Massachusetts recipient of the CDC Childhood Immunization Award.
Recently, Meissner endorsed a move by the CDC to stop recommending COVID-19 vaccines for healthy children and pregnant people. Those changes were criticized by many major medical groups, including the American College for Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine.
In August 2021, he expressed opposition to requiring that children wear a mask to prevent the spread of COVID, arguing that kids suffered negative consequences and that the availability of vaccines for adults undermined the need for children to mask. He has also opposed vaccine mandates and signed onto the Great Barrington Declaration.
Who is he? An emergency room doctor from Los Angeles
Vaccine experience: Pagano does not appear to have any research or work experience related to vaccines readily available.
Who is she? A California-based regional director of the National Association of Catholic Nurses and board member of the National Vaccine Information Center, an anti-vax organization that many doctors and public health researchers say is a leading source of vaccine misinformation.
Vaccine experience: Pebsworth has argued that vaccines cause chronic illnesses and disabilities in children, a false talking point frequently used by vaccine opponents. She has also done work questioning the safety of the HPV vaccine, which Kennedy also opposes. The uptake of the HPV vaccine has contributed to substantial decreases in cervical cancer.
Who is he? A Virginia-based OB-GYN and medical technology executive, working currently as interim chief medical officer at a startup trying to use artificial intelligence to deliver medicines. His Linkedin also lists him as a board member for LarreaRx, a supplement company.
Vaccine experience: Ross does not appear to have any research or work experience related to vaccines readily available.
The post RFK Jr. fired everyone on a key vaccine panel. Here's who he replaced them with. appeared first on The 19th.
News that represents you, in your inbox every weekday. Subscribe to our free, daily newsletter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
44 minutes ago
- Boston Globe
How a purge at one obscure panel could disrupt US vaccinations
On Monday, Kennedy, long a vaccine skeptic, Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up On the social platform X, he promised not to replace the panel's experts with 'ideological anti-vaxxers.' On Wednesday, Kennedy Advertisement For years, Kennedy has argued that American children receive too many shots and has falsely claimed that vaccines are not tested in placebo-controlled studies. Critics fear he is now setting the stage for a rollback of federal recommendations. Robert F. Kennedy Jr., Secretary of Health and Human Services, testifies on Capitol Hill in Washington, May 14, 2025. HAIYUN JIANG/NYT 'I'm very, very worried about young children in this country,' said Dr. Helen Chu, professor of medicine at the University of Washington and one of the committee members who was fired. If the panel's new members 'don't believe in vaccines, then I think it puts us in a very dangerous place.' Advertisement Richard Hughes IV, who teaches vaccine law at George Washington University, predicted that the new committee would move to pare back the childhood vaccination schedule 'relatively quickly.' The Department of Health and Human Services did not respond to a request for comment. 'All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,' Kennedy said in a message on X. 'They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations.' He also acknowledged that the panel would 'review safety and efficacy data for the current schedule as well.' The upheaval arrives as measles infections approach the highest level in decades; whooping cough has risen significantly, too, compared with this time last year. Steep cuts to global immunization programs also make it more likely that infectious diseases, such as polio, may reach American shores. Alarmed, members of the House Committee on Oversight and Government Reform have asked Kennedy to provide all communications and documents related to the dismissal of the committee and a 'detailed description of the rationale for removing each individual' by June 24, according to a letter obtained by The New York Times. The American Medical Association called for an immediate reversal of the purge and resolved to 'identify and evaluate' alternative sources of advice on vaccines. It is unclear whether Kennedy will appoint more members -- there is no required minimum -- before the next scheduled meeting at the end of June. And no one can say whether or how the decisions of the reshaped panel may diverge from current recommendations. Advertisement But any softening of federal recommendations regarding vaccination would ripple through the nation in unpredictable ways. Access to the shots eventually may depend on where you live, which insurance policy you hold and which doctor you see, experts said. 'That obviously is going to decrease the number of people who are protected with these vaccines,' said Dr. Mysheika Roberts, the health commissioner of Columbus, Ohio. 'I am concerned about what that means about herd immunity, what that means about outbreaks and infections.' Under the Affordable Care Act, insurance companies are required to cover the cost of any vaccine recommended by the ACIP. Losing that endorsement means that some insurance companies may choose not to pay for immunizations. Nor could those shots be offered for free through the Vaccines for Children program. The measles vaccine can cost up to $250 and the four-dose polio series up to $340. 'You'd essentially have a two-tier system where people who have cash at hand can purchase their own vaccines if they're not recommended, and those who don't have the money may have to go without,' said Dr. Yvonne Maldonado, a pediatrician at Stanford University and one of the fired panelists. The panel could take a more measured approach, perhaps advising that a doctor's sign-off should be required for some immunizations. The vaccines program would still cover it, but reimbursement from private insurers would be more difficult to enforce, Hughes said. The Vaccines for Children program was created after a measles epidemic from 1989 to 1991 led to tens of thousands of cases and hundreds of deaths. More than half of the infected children were unvaccinated even though many had seen a doctor, because they could not afford the shots, according to the CDC. Advertisement Cutting back on free access to immunizations 'is not a strategy to even think about -- only vaccinating potentially the half of the population that has health insurance,' Chu said. If measles continues to resurge, for example, even vaccinated people will be at risk, she said. Vaccinations are not profitable for clinics, and reduced demand could mean that fewer places bother to offer the shots. 'In places where you know there's a large anti-vax sentiment, there may not be financial incentive, or any incentive, to keep those vaccines in stock,' she said. ACIP makes recommendations for immunizations. But the authority to mandate them rests with the states. Even if the federal government walked away from some recommendations, most, if not all, states are likely to maintain the current mandates for school-age children, said Claire Hannan, executive director of the Association of Immunization Managers, which represents state and local officials. 'Even where legislators are chipping away at requirements and mandates, there's a commitment to protect children,' she said. Still, she added, 'our members are very confused.' Now some scientists are considering establishing alternatives to federal guidance on vaccines. 'The new ACIP cannot be trusted to oversee unbiased and scientifically sound vaccine policy development,' said Michael Osterholm, a public health researcher at the University of Minnesota. He and other experts have formed a new group, called the Vaccine Integrity Project, to offer science-based advice on immunization. Members of the ACIP are usually vetted thoroughly. It took more than four months for Roberts, who was set to join the panel in July, to be accepted, and several more weeks to fill out at least 50 forms, including disclosures of conflict of interest. The committee's members typically rotate in staggered four-year terms to ensure some continuity and institutional memory. Advertisement Mina Zadeh, a CDC scientist, has been named to oversee the committee, but the rest of her team has not been set up. Staff members who lead the committee's work groups may meet with her 'starting early next week,' according to a recording of an internal meeting obtained by the Times. But the panel's next meeting is scheduled to begin June 25. Dr. Adam Ratner, a pediatric infectious diseases physician and expert on vaccine policy, said he worried the new members could not be prepared on such short notice and without the help of previous members or CDC personnel. 'This raises the question of whether the goal here is for ACIP to be able to do its job,' he added. 'Kennedy has accused the prior committee members of conflicts of interest and for rubber-stamping things, but I think that's exactly what we're looking at with this group.' This article originally appeared in .
Politico
an hour ago
- Politico
The ACIP fallout
Presented by THE NEW MAKEUP OF CDC'S VACCINE PANEL — Days after Health and Human Services Secretary Robert F. Kennedy Jr. purged the Centers for Disease Control and Prevention's panel of vaccine experts and appointed eight replacements, Washington is bracing for the impact on vaccination access and public health, POLITICO's Sophie Gardner and Lauren report. 'If we have a system that has been dismantled — one that allowed for open, evidence-based decision-making and that supported transparent and clear dialogue about vaccines — and then we replace it with a process that's driven largely by one person's beliefs, that creates a system that cannot be trusted,' said Dr. Helen Chu, a University of Washington School of Medicine professor who was dismissed from the vaccine panel this week. In the absence of independent, unbiased advice, she added, 'We can't trust that safe and effective vaccines will be available for use in the United States.' The CDC's Advisory Committee on Immunization Practices helps set the CDC's childhood and adult immunization schedules, and several state and federal laws reference ACIP recommendations — including the Affordable Care Act, which requires health plans to cover vaccines the committee recommends for routine use without cost-sharing. Kennedy's sweeping moves in his first few months on the job underscore the broad mandate President Donald Trump gave him to remake the federal health department. 'Secretary Kennedy is restoring trust by demanding radical transparency and ending the complacency that defined past public health failures,' HHS spokesperson Andrew Nixon told POLITICO in a statement Thursday, noting that Kennedy's commitment to putting 'accountability and radical transparency first' will 'restore trust in our public health system.' Biden's final push: ACIP voting members usually serve four-year terms — and STAT has reported that the Biden administration intentionally stacked the committee's membership, selecting replacements for members whose terms were set to expire in June. Even so, Kennedy's decision to fire all of the panel's members and replace them is unprecedented. The HHS secretary wields broad authority to manage the panel as he sees fit under federal law. And the slate he announced Wednesday includes several people known for questioning the safety of either messenger RNA vaccines specifically or, more broadly, the childhood schedule. RFK's informal advisor: Dr. Jeffrey Klausner, a former public health official in California, has informally advised Kennedy since the November election, including compiling a list of names for new ACIP members who he thought would balance public health imperatives with vaccine safety concerns. None of his suggestions made the cut so far, he told POLITICO. What's next: Kennedy said the new members will 'review safety and efficacy data for the current schedule,' raising questions about how the new panel may seek to change recommendations relied upon by pediatricians nationwide. But leaders in the public health establishment say his actions are more likely to do the opposite, arguing he distorts scientific data to suit his message. 'What he's doing is undermining trust,' said Tom Frieden, who led the Centers for Disease Control and Prevention during Barack Obama's presidency. IT'S FRIDAY. WELCOME BACK TO PRESCRIPTION PULSE. We're waiting on the House Appropriations Committee to resume consideration of the FDA's funding bill after a lengthy markup paused early Thursday morning. Send your tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). In Congress HOUSE CLEARS FUNDING CLAWBACK — House Republicans narrowly advanced a request from the White House to claw back $9.4 billion that lawmakers have already approved for public media and foreign assistance by a 214-212 vote Thursday, POLITICO's Katherine Tully-McManus and Jennifer Scholtes report. The package now heads to the Senate, where Republicans are discussing whether they can amend it — despite the complicated mechanics of the recissions process. It faced opposition from some Republican lawmakers concerned about slashing the President's Emergency Plan for AIDS Relief, or PEPFAR, and how emergency alerts could be impacted by the public media cuts. GENERIC SHORTAGE BILL — A bipartisan bill that aims to strengthen the supply chain for critical generic drugs by awarding federal contracts to drugmakers to maintain reserves of medications and their key ingredients was again introduced in the Senate on Thursday. The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act contracts would prioritize domestic manufacturers. The issue of generic shortages remains a focus for lawmakers after the Covid-19 pandemic demonstrated the reliance of the U.S. on other nations for certain medical products. Sens. Gary Peters(D-Mich.), Marsha Blackburn (R-Tenn.), Tim Kaine (D-Va.) and Ted Budd (R-N.C.) also asked the Government Accountability Office to look at 'underutilized domestic manufacturing capacity' in a separate letter. CASSIDY FLOATS MFN-LIKE DRAFT BILL — Senate Health, Education, Labor and Pensions Chair Bill Cassidy (R-La.) is circulating a draft bill that looks awfully similar on first glance to President Donald Trump's most favored nations push. But the proposal is not the same, POLITICO's Robert King and David report. It seeks to adjust the clawback based on how wealthy other countries are, and the bill would only apply to a list of 50 drugs that cost Medicare the most money that is updated once every three years. Notably, it asks the government to claw back money from drugmakers instead of telling them to sell their medicines at costs similar to what they charge abroad. Cassidy's office declined to comment on the legislation. The draft's fate is unclear, but it remains noteworthy given the GOP's consistent reluctance to impose price controls on pharmaceuticals. Other MFN proposals usually state that drugmakers can't charge more in the U.S. for their products than they charge a basket of other rich countries. The draft bill states the policy would apply to countries with a nominal gross domestic product that is not less than 3 percent of the U.S. 'My read is more that he's trying desperately to get on the bandwagon without actually doing the thing,' said Steve Knievel, a drug pricing expert at liberal advocacy group Public Citizen. 'It is good that at least they're not trying to penalize countries that are much poorer than us by trying to force U.S. prices on them.' Industry Intel MODERNA GETS FDA GREEN LIGHT — Moderna's respiratory syncytial virus vaccine received FDA approval for adults ages 18 to 59 who are at an increased risk for the disease, the company announced Thursday. 'RSV poses a serious health risk to adults with certain chronic conditions, and today's approval marks an important step forward in our ability to protect additional populations from severe illness from RSV,' Moderna CEO Stéphane Bancel said in a press release. The company already received approval for the vaccine in May 2024 for those ages 60 and older. Pharma Worldwide EU WEIGHS TOBACCO TAX HIKE — The European Commission is weighing a tax increase of 258 percent on rolling tobacco and 139 percent on cigarettes, according to an impact assessment obtained by POLITICO. The body wants to start taxing vapes and heated tobacco products too. The document attributes about 40 percent of the decline in smoking in the EU over the past decade to taxes. But it states the 'current minimum tax rates have lost traction in terms of making an effective contribution to reducing tobacco consumption.' Document Drawer Veritas Health Policy is scheduled to meet with the White House Office of Information and Regulatory Affairs on Monday to discuss the Health Resources and Services Administration's 340B rebate guidance. On Tuesday, the National Association of Community Health Centers is scheduled to meet OIRA on the same topic. And on Wednesday, the American Hospital Association has its turn scheduled. WHAT WE'RE READING GOP senators met with HHS Secretary Robert F. Kennedy Jr. earlier this week to discuss concerns with the Make America Healthy Again report, POLITICO's Grace Yarrow reports. The lowest-income households in America would lose $1,600 a year in federal resources due in large part to safety-net cuts, the Congressional Budget Office predicted Thursday, POLITICO's Jennifer Scholtes reports. For the highest income households, resources would increase by $12,000 per year, in large part due to tax cuts under consideration.
Yahoo
an hour ago
- Yahoo
Moderna wins FDA OK to widen use of RSV vaccine
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The Food and Drug Administration has approved wider use of Moderna's respiratory syncytial virus vaccine in a boost for a company that's been negatively impacted by the recent leadership changes atop U.S. public health agencies. The shot, dubbed mResvia, was cleared on Thursday for adults aged 18 to 59 who are at high risk for increased risk of RSV-related disease. Prior to the label expansion, Moderna's shot was only available to adults 60 or older. "RSV poses a serious health risk to adults with certain chronic conditions, and today's approval marks an important step forward in our ability to protect additional populations from severe illness from RSV," Moderna CEO Stéphane Bancel said in a statement. The expansion is a much-needed win for Moderna, which has been among those hardest hit by the changes in vaccine policy enacted by new FDA leaders Martin Makary and Vinay Prasad, as well as Health and Human Services Secretary Robert F. Kennedy Jr. Makary and Prasad, for instance, have outlined stricter approval standards for COVID-19 vaccines and called for developers to perform more placebo-controlled trials. Kennedy Jr., who has long been critical of the kind of messenger RNA vaccines Moderna is known for, has said the Centers for Disease Control and Prevention would remove COVID shots from the recommended immunization schedules for pregnant women and healthy children. He also, this week, overhauled the CDC panel that determines who should get which vaccines and shapes private insurance coverage for inoculations. Some of the new members of the eight-person panel include vaccine skeptics and doctors with different focus areas. The changes at the CDC could have important implications for Moderna. In April, the CDC panel recommended broadening use of RSV shots to enable adults 50 to 59 years of age who are at a higher risk of severe RSV-related disease to get vaccinated. But the agency still doesn't have an acting director, and Kennedy Jr. has yet to endorse that recommendation. Without a formal clearance, insurers are not required to cover the cost of the shot. The newly constituted panel's first meeting is scheduled for June 25-27, and will be closely watched by investors. In a research note Friday, William Blair analyst Myles Minter noted that the gathering will be 'important for sentiment in the vaccine sector, which continues to decline.' Minter believes Moderna, which has seen its share price plummet more than 80% over the last year, will need to significantly cut costs to meet its objective of breaking even financially by 2028.
